Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

The role of dopamine and serotonin in regulating bone mass and strength: studies on dopamine and serotonin transporter null mice.

Bliziotes M, Gunness M, Eshleman A, Wiren K.

J Musculoskelet Neuronal Interact. 2002 Mar;2(3):291-5.

PMID:
15758457
[PubMed]
Free Article
2.

Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

Bliziotes MM, Eshleman AJ, Zhang XW, Wiren KM.

Bone. 2001 Nov;29(5):477-86.

PMID:
11704501
[PubMed - indexed for MEDLINE]
3.

Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene.

Bliziotes M, McLoughlin S, Gunness M, Fumagalli F, Jones SR, Caron MG.

Bone. 2000 Jan;26(1):15-9.

PMID:
10617152
[PubMed - indexed for MEDLINE]
4.

Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.

Bliziotes M, Eshleman A, Burt-Pichat B, Zhang XW, Hashimoto J, Wiren K, Chenu C.

Bone. 2006 Dec;39(6):1313-21. Epub 2006 Aug 1.

PMID:
16884969
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Bone density, strength, and formation in adult cathepsin K (-/-) mice.

Pennypacker B, Shea M, Liu Q, Masarachia P, Saftig P, Rodan S, Rodan G, Kimmel D.

Bone. 2009 Feb;44(2):199-207. doi: 10.1016/j.bone.2008.08.130. Epub 2008 Sep 19.

PMID:
18845279
[PubMed - indexed for MEDLINE]
6.

Spinal cord injury causes more damage to bone mass, bone structure, biomechanical properties and bone metabolism than sciatic neurectomy in young rats.

Jiang SD, Jiang LS, Dai LY.

Osteoporos Int. 2006 Oct;17(10):1552-61. Epub 2006 Jul 28.

PMID:
16874443
[PubMed - indexed for MEDLINE]
7.

Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice.

Daws LC, Munn JL, Valdez MF, Frosto-Burke T, Hensler JG.

J Neurochem. 2007 May;101(3):641-51. Epub 2007 Jan 24.

PMID:
17254018
[PubMed - indexed for MEDLINE]
8.

Fluoxetine treatment increases trabecular bone formation in mice.

Battaglino R, Vokes M, Schulze-Späte U, Sharma A, Graves D, Kohler T, Müller R, Yoganathan S, Stashenko P.

J Cell Biochem. 2007 Apr 15;100(6):1387-94.

PMID:
17041947
[PubMed - indexed for MEDLINE]
9.

Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.

Chen N, Reith ME.

J Neurochem. 2007 Apr;101(2):377-88. Epub 2007 Jan 22.

PMID:
17250655
[PubMed - indexed for MEDLINE]
10.

(+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.

Ni W, Wilhelm CS, Bader M, Murphy DL, Lookingland K, Watts SW.

J Pharmacol Exp Ther. 2005 Sep;314(3):953-60. Epub 2005 May 18.

PMID:
15901794
[PubMed - indexed for MEDLINE]
Free Article
11.

Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.

Jennings KA, Sheward WJ, Harmar AJ, Sharp T.

Neuropharmacology. 2008 Apr;54(5):776-83. doi: 10.1016/j.neuropharm.2007.12.001. Epub 2007 Dec 14.

PMID:
18241894
[PubMed - indexed for MEDLINE]
12.

Aberrant accumulation of serotonin in dopaminergic neurons.

Mössner R, Simantov R, Marx A, Lesch KP, Seif I.

Neurosci Lett. 2006 Jun 19;401(1-2):49-54. Epub 2006 Apr 25.

PMID:
16638624
[PubMed - indexed for MEDLINE]
13.

Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.

Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Shen CL, Yeh JK.

J Nutr Sci Vitaminol (Tokyo). 2006 Feb;52(1):21-7.

PMID:
16637226
[PubMed - indexed for MEDLINE]
Free Article
14.

High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice.

Cao JJ, Gregoire BR, Gao H.

Bone. 2009 Jun;44(6):1097-104. doi: 10.1016/j.bone.2009.02.017. Epub 2009 Mar 3.

PMID:
19264159
[PubMed - indexed for MEDLINE]
15.

Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.

Li M, Pan LC, Simmons HA, Li Y, Healy DR, Robinson BS, Ke HZ, Brown TA.

Bone. 2006 Oct;39(4):796-806. Epub 2006 Jun 8.

PMID:
16759917
[PubMed - indexed for MEDLINE]
16.

Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.

Iida-Klein A, Lu SS, Cosman F, Lindsay R, Dempster DW.

Bone. 2007 Feb;40(2):391-8. Epub 2006 Oct 20.

PMID:
17056311
[PubMed - indexed for MEDLINE]
17.

Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice.

Zhao S, Edwards J, Carroll J, Wiedholz L, Millstein RA, Jaing C, Murphy DL, Lanthorn TH, Holmes A.

Neuroscience. 2006 Jun 19;140(1):321-34. Epub 2006 Mar 20.

PMID:
16542782
[PubMed - indexed for MEDLINE]
18.
19.

Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.

Wiesinger JA, Buwen JP, Cifelli CJ, Unger EL, Jones BC, Beard JL.

J Neurochem. 2007 Jan;100(1):167-79.

PMID:
17227437
[PubMed - indexed for MEDLINE]
20.

[Serotonin reuptake inhibitors may increase the risk of osteoporosis].

Lerner UH.

Lakartidningen. 2005 Sep 26-Oct 2;102(39):2746-9. Review. Swedish.

PMID:
16245546
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk